Urology therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Gaucher Disease Type II (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... information on the therapeutics under development for Gaucher Disease Type II, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descrip......" | 30-Apr-2021 | $2000 | |
Hutchinson-Gilford Progeria (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... mprehensive information on the therapeutics under development for Hutchinson-Gilford Progeria, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also co......" | 30-Apr-2021 | $2000 | |
Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... nsive information on the therapeutics under development for Maple Syrup Urine Disease, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the......" | 30-Apr-2021 | $2000 | |
Angelman Syndrome (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... therapeutics under development for Angelman Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Act......" | 30-Apr-2021 | $2000 | |
Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021By Global Markets Direct "...... peutics under development for Turner Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of t......" | 30-Apr-2021 | $2000 | |
Primary Hyperoxaluria Type I (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... andscape.
The report provides comprehensive information on the therapeutics under development for Primary Hyperoxaluria Type I, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administrati......" | 30-Apr-2021 | $2000 | |
IgA Nephropathy (Berger's Disease) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... isease) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for IgA Nephropathy (Berger's Disease), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA......" | 30-Apr-2021 | $2000 | |
Focal Segmental Glomerulosclerosis (FSGS) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... al Glomerulosclerosis (FSGS) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Focal Segmental Glomerulosclerosis (FSGS), complete with analysis by Stage of Development, Drug Targ......" | 30-Apr-2021 | $2000 | |
Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... evelopment, 2021 provides an overview of the Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Interstitial ......" | 30-Apr-2021 | $2000 | |
Kidney Disease (Nephropathy) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021By Global Markets Direct "...... andscape.
The report provides comprehensive information on the therapeutics under development for Kidney Disease (Nephropathy), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administrati......" | 30-Apr-2021 | $2000 | |
|